Analysis: Large pharma companies do little new drug innovation
Among their top-selling drugs, 76% of Pfizer's and 89% of J&J's were developed by other companies and account for nearly 90% of revenues.
Continue Reading![](https://s0.storage.snapzu.com/favicons/s/t/a/t/www.statnews.com.png)
Among their top-selling drugs, 76% of Pfizer's and 89% of J&J's were developed by other companies and account for nearly 90% of revenues.
Continue Reading
Join the Discussion